Region
Featured experience
Tokyo Metro privatization and ¥348.6 billion IPO
The deal is the largest Japanese IPO since 2018
Metaplanet ¥212.9 billion stock offering
The proceeds will be used to fund in part the acquisition of additional bitcoin
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent going-private offer to acquire Sogou
Davis Polk is advising Tencent Holdings Limited in connection with its preliminary non-binding proposal to acquire all of…
CIFI Holdings (Group) $300 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $300 million Regulation S offering by CIFI Holdings (Group)…
Trip.com $500 million exchangeable senior notes offering
Davis Polk advised the initial purchasers in a Regulation S offering by Trip.com Group Limited of $500 million…
Metropolis of Tokyo $1.5 billion bond offering
Davis Polk advised The Metropolis of Tokyo in connection with its $1.5 billion Rule 144A/Regulation S offering of 0.750%…
RiseSun Real Estate Development $250 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with the Regulation S offering of $250 million principal amount…
Google investment in Reliance Industries’ Jio Platforms unit
Davis Polk is advising Reliance Industries Limited and Jio Platforms Limited in connection with binding agreements entered…
Mizuho Financial Group $2.5 billion senior notes offering
Davis Polk advised the joint lead managers in connection with Mizuho Financial Group, Inc.’s SEC-registered takedown…
Golden Wheel Tiandi $170 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $170 million Regulation S offering by Golden Wheel Tiandi…
Ocumension Therapeutics HK$1.55 billion IPO and HKEX listing
Davis Polk advised the underwriters in the initial public offering of Ocumension Therapeutics on the Hong Kong Stock…
Shenzhen Hepalink Pharmaceutical Group HK$4.05 billion IPO
Davis Polk advised Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in connection with its initial public offering and…